nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—ORM1—Vemurafenib—melanoma	0.177	0.307	CbGbCtD
Nortriptyline—ALB—melanoma	0.132	1	CbGaD
Nortriptyline—ALB—Vemurafenib—melanoma	0.0747	0.129	CbGbCtD
Nortriptyline—CYP2E1—Dacarbazine—melanoma	0.0592	0.102	CbGbCtD
Nortriptyline—CYP1A2—Carmustine—melanoma	0.0565	0.0977	CbGbCtD
Nortriptyline—CYP1A2—Vemurafenib—melanoma	0.0447	0.0772	CbGbCtD
Nortriptyline—CYP3A4—Temozolomide—melanoma	0.0427	0.0739	CbGbCtD
Nortriptyline—CYP2D6—Vemurafenib—melanoma	0.0368	0.0636	CbGbCtD
Nortriptyline—CYP1A2—Dacarbazine—melanoma	0.0342	0.0592	CbGbCtD
Nortriptyline—CYP3A4—Vemurafenib—melanoma	0.0234	0.0405	CbGbCtD
Nortriptyline—CYP3A5—Docetaxel—melanoma	0.0206	0.0356	CbGbCtD
Nortriptyline—CYP3A4—Docetaxel—melanoma	0.00803	0.0139	CbGbCtD
Nortriptyline—Cutaneous hypersensitivity—Docetaxel—melanoma	0.00263	0.0218	CcSEcCtD
Nortriptyline—Olopatadine—S100B—melanoma	0.0022	0.584	CrCbGaD
Nortriptyline—Tongue discolouration—Temozolomide—melanoma	0.00199	0.0166	CcSEcCtD
Nortriptyline—Drug fever—Docetaxel—melanoma	0.00192	0.016	CcSEcCtD
Nortriptyline—Extrapyramidal disorder—Temozolomide—melanoma	0.00128	0.0106	CcSEcCtD
Nortriptyline—Cholestasis—Temozolomide—melanoma	0.00127	0.0106	CcSEcCtD
Nortriptyline—Petechiae—Temozolomide—melanoma	0.00117	0.00974	CcSEcCtD
Nortriptyline—Eosinophilia—Vemurafenib—melanoma	0.00117	0.00974	CcSEcCtD
Nortriptyline—Weight decreased—Vemurafenib—melanoma	0.00107	0.0089	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Vemurafenib—melanoma	0.00103	0.0086	CcSEcCtD
Nortriptyline—Coordination abnormal—Carmustine—melanoma	0.00102	0.00845	CcSEcCtD
Nortriptyline—Aplastic anaemia—Dactinomycin—melanoma	0.001	0.00832	CcSEcCtD
Nortriptyline—Coordination abnormal—Temozolomide—melanoma	0.000982	0.00816	CcSEcCtD
Nortriptyline—Oedema peripheral—Vemurafenib—melanoma	0.000933	0.00776	CcSEcCtD
Nortriptyline—Disorientation—Bleomycin—melanoma	0.000927	0.00771	CcSEcCtD
Nortriptyline—Aplastic anaemia—Temozolomide—melanoma	0.000905	0.00753	CcSEcCtD
Nortriptyline—Gynaecomastia—Carmustine—melanoma	0.000893	0.00742	CcSEcCtD
Nortriptyline—Throat sore—Docetaxel—melanoma	0.00089	0.0074	CcSEcCtD
Nortriptyline—Eye disorder—Vemurafenib—melanoma	0.000885	0.00736	CcSEcCtD
Nortriptyline—Oropharyngeal discomfort—Docetaxel—melanoma	0.000882	0.00733	CcSEcCtD
Nortriptyline—Dermatitis atopic—Docetaxel—melanoma	0.000866	0.0072	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Bleomycin—melanoma	0.000847	0.00704	CcSEcCtD
Nortriptyline—Alopecia—Vemurafenib—melanoma	0.000837	0.00696	CcSEcCtD
Nortriptyline—Dysgeusia—Vemurafenib—melanoma	0.000808	0.00672	CcSEcCtD
Nortriptyline—Eye pain—Carmustine—melanoma	0.000802	0.00667	CcSEcCtD
Nortriptyline—CHRM5—skin epidermis—melanoma	0.000799	0.132	CbGeAlD
Nortriptyline—Vascular purpura—Temozolomide—melanoma	0.000782	0.00651	CcSEcCtD
Nortriptyline—Eye pain—Temozolomide—melanoma	0.000775	0.00645	CcSEcCtD
Nortriptyline—Hot flush—Temozolomide—melanoma	0.000748	0.00622	CcSEcCtD
Nortriptyline—Menopausal symptoms—Temozolomide—melanoma	0.000742	0.00617	CcSEcCtD
Nortriptyline—Purpura—Temozolomide—melanoma	0.000726	0.00604	CcSEcCtD
Nortriptyline—Oropharyngeal pain—Docetaxel—melanoma	0.000705	0.00586	CcSEcCtD
Nortriptyline—Pancytopenia—Bleomycin—melanoma	0.000681	0.00566	CcSEcCtD
Nortriptyline—Ataxia—Carmustine—melanoma	0.000681	0.00566	CcSEcCtD
Nortriptyline—Ataxia—Temozolomide—melanoma	0.000658	0.00547	CcSEcCtD
Nortriptyline—Weight decreased—Bleomycin—melanoma	0.000649	0.00539	CcSEcCtD
Nortriptyline—Pancytopenia—Dactinomycin—melanoma	0.000635	0.00528	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Bleomycin—melanoma	0.00063	0.00524	CcSEcCtD
Nortriptyline—Hypotension—Vemurafenib—melanoma	0.000629	0.00523	CcSEcCtD
Nortriptyline—Myocardial infarction—Bleomycin—melanoma	0.000627	0.00521	CcSEcCtD
Nortriptyline—Stomatitis—Bleomycin—melanoma	0.000623	0.00518	CcSEcCtD
Nortriptyline—Pancytopenia—Carmustine—melanoma	0.000594	0.00494	CcSEcCtD
Nortriptyline—Sweating increased—Temozolomide—melanoma	0.000589	0.0049	CcSEcCtD
Nortriptyline—Decreased appetite—Vemurafenib—melanoma	0.000585	0.00486	CcSEcCtD
Nortriptyline—Stomatitis—Dactinomycin—melanoma	0.000581	0.00483	CcSEcCtD
Nortriptyline—Fatigue—Vemurafenib—melanoma	0.00058	0.00482	CcSEcCtD
Nortriptyline—Constipation—Vemurafenib—melanoma	0.000576	0.00479	CcSEcCtD
Nortriptyline—Pancytopenia—Temozolomide—melanoma	0.000574	0.00478	CcSEcCtD
Nortriptyline—Hypoaesthesia—Bleomycin—melanoma	0.000571	0.00475	CcSEcCtD
Nortriptyline—Pollakiuria—Temozolomide—melanoma	0.000559	0.00465	CcSEcCtD
Nortriptyline—Erectile dysfunction—Temozolomide—melanoma	0.000557	0.00463	CcSEcCtD
Nortriptyline—Agranulocytosis—Dactinomycin—melanoma	0.000556	0.00463	CcSEcCtD
Nortriptyline—Weight increased—Temozolomide—melanoma	0.00055	0.00458	CcSEcCtD
Nortriptyline—Weight decreased—Temozolomide—melanoma	0.000547	0.00455	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Carmustine—melanoma	0.000547	0.00455	CcSEcCtD
Nortriptyline—Stomatitis—Carmustine—melanoma	0.000544	0.00452	CcSEcCtD
Nortriptyline—Hepatitis—Dactinomycin—melanoma	0.000535	0.00445	CcSEcCtD
Nortriptyline—Flushing—Bleomycin—melanoma	0.000533	0.00443	CcSEcCtD
Nortriptyline—Body temperature increased—Vemurafenib—melanoma	0.000532	0.00442	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Temozolomide—melanoma	0.000529	0.0044	CcSEcCtD
Nortriptyline—Stomatitis—Temozolomide—melanoma	0.000526	0.00437	CcSEcCtD
Nortriptyline—Alopecia—Bleomycin—melanoma	0.000507	0.00422	CcSEcCtD
Nortriptyline—Hallucination—Carmustine—melanoma	0.000498	0.00414	CcSEcCtD
Nortriptyline—Hypoaesthesia—Carmustine—melanoma	0.000498	0.00414	CcSEcCtD
Nortriptyline—Hot flush—Docetaxel—melanoma	0.000498	0.00414	CcSEcCtD
Nortriptyline—Flushing—Dactinomycin—melanoma	0.000497	0.00413	CcSEcCtD
Nortriptyline—Hypersensitivity—Vemurafenib—melanoma	0.000496	0.00412	CcSEcCtD
Nortriptyline—Oedema peripheral—Carmustine—melanoma	0.000494	0.0041	CcSEcCtD
Nortriptyline—Menopausal symptoms—Docetaxel—melanoma	0.000493	0.0041	CcSEcCtD
Nortriptyline—Hepatitis—Temozolomide—melanoma	0.000484	0.00403	CcSEcCtD
Nortriptyline—Asthenia—Vemurafenib—melanoma	0.000483	0.00402	CcSEcCtD
Nortriptyline—Hypoaesthesia—Temozolomide—melanoma	0.000482	0.00401	CcSEcCtD
Nortriptyline—Hallucination—Temozolomide—melanoma	0.000482	0.00401	CcSEcCtD
Nortriptyline—Oedema peripheral—Temozolomide—melanoma	0.000477	0.00397	CcSEcCtD
Nortriptyline—Pruritus—Vemurafenib—melanoma	0.000476	0.00396	CcSEcCtD
Nortriptyline—Alopecia—Dactinomycin—melanoma	0.000473	0.00393	CcSEcCtD
Nortriptyline—Eye disorder—Carmustine—melanoma	0.000468	0.00389	CcSEcCtD
Nortriptyline—Flushing—Carmustine—melanoma	0.000465	0.00387	CcSEcCtD
Nortriptyline—Ill-defined disorder—Bleomycin—melanoma	0.000464	0.00385	CcSEcCtD
Nortriptyline—Diarrhoea—Vemurafenib—melanoma	0.000461	0.00383	CcSEcCtD
Nortriptyline—Eye disorder—Temozolomide—melanoma	0.000452	0.00376	CcSEcCtD
Nortriptyline—Tinnitus—Temozolomide—melanoma	0.000451	0.00375	CcSEcCtD
Nortriptyline—Malaise—Bleomycin—melanoma	0.000451	0.00375	CcSEcCtD
Nortriptyline—Flushing—Temozolomide—melanoma	0.000449	0.00374	CcSEcCtD
Nortriptyline—Arrhythmia—Carmustine—melanoma	0.000448	0.00372	CcSEcCtD
Nortriptyline—Leukopenia—Bleomycin—melanoma	0.000447	0.00372	CcSEcCtD
Nortriptyline—Dizziness—Vemurafenib—melanoma	0.000445	0.0037	CcSEcCtD
Nortriptyline—Alopecia—Carmustine—melanoma	0.000443	0.00368	CcSEcCtD
Nortriptyline—Ataxia—Docetaxel—melanoma	0.000438	0.00364	CcSEcCtD
Nortriptyline—Ill-defined disorder—Dactinomycin—melanoma	0.000432	0.0036	CcSEcCtD
Nortriptyline—Vomiting—Vemurafenib—melanoma	0.000428	0.00356	CcSEcCtD
Nortriptyline—Alopecia—Temozolomide—melanoma	0.000428	0.00356	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Docetaxel—melanoma	0.000425	0.00353	CcSEcCtD
Nortriptyline—Rash—Vemurafenib—melanoma	0.000424	0.00353	CcSEcCtD
Nortriptyline—Dermatitis—Vemurafenib—melanoma	0.000424	0.00353	CcSEcCtD
Nortriptyline—Headache—Vemurafenib—melanoma	0.000422	0.00351	CcSEcCtD
Nortriptyline—Discomfort—Bleomycin—melanoma	0.00042	0.00349	CcSEcCtD
Nortriptyline—Malaise—Dactinomycin—melanoma	0.00042	0.00349	CcSEcCtD
Nortriptyline—Leukopenia—Dactinomycin—melanoma	0.000417	0.00347	CcSEcCtD
Nortriptyline—Dysgeusia—Temozolomide—melanoma	0.000413	0.00343	CcSEcCtD
Nortriptyline—Confusional state—Bleomycin—melanoma	0.000411	0.00342	CcSEcCtD
Nortriptyline—Vision blurred—Carmustine—melanoma	0.000411	0.00342	CcSEcCtD
Nortriptyline—Tremor—Carmustine—melanoma	0.000409	0.0034	CcSEcCtD
Nortriptyline—Oedema—Bleomycin—melanoma	0.000408	0.00339	CcSEcCtD
Nortriptyline—Agitation—Carmustine—melanoma	0.000401	0.00333	CcSEcCtD
Nortriptyline—Nausea—Vemurafenib—melanoma	0.0004	0.00332	CcSEcCtD
Nortriptyline—Thrombocytopenia—Bleomycin—melanoma	0.000399	0.00332	CcSEcCtD
Nortriptyline—Vision blurred—Temozolomide—melanoma	0.000397	0.0033	CcSEcCtD
Nortriptyline—Tremor—Temozolomide—melanoma	0.000395	0.00328	CcSEcCtD
Nortriptyline—Discomfort—Dactinomycin—melanoma	0.000392	0.00326	CcSEcCtD
Nortriptyline—Ill-defined disorder—Temozolomide—melanoma	0.000391	0.00325	CcSEcCtD
Nortriptyline—Leukopenia—Carmustine—melanoma	0.00039	0.00325	CcSEcCtD
Nortriptyline—Anorexia—Bleomycin—melanoma	0.000389	0.00323	CcSEcCtD
Nortriptyline—Agitation—Temozolomide—melanoma	0.000387	0.00322	CcSEcCtD
Nortriptyline—Pancytopenia—Docetaxel—melanoma	0.000382	0.00318	CcSEcCtD
Nortriptyline—Hypotension—Bleomycin—melanoma	0.000381	0.00317	CcSEcCtD
Nortriptyline—Oedema—Dactinomycin—melanoma	0.00038	0.00316	CcSEcCtD
Nortriptyline—Malaise—Temozolomide—melanoma	0.00038	0.00316	CcSEcCtD
Nortriptyline—Convulsion—Carmustine—melanoma	0.000378	0.00314	CcSEcCtD
Nortriptyline—Leukopenia—Temozolomide—melanoma	0.000377	0.00314	CcSEcCtD
Nortriptyline—Hypertension—Carmustine—melanoma	0.000377	0.00313	CcSEcCtD
Nortriptyline—Palpitations—Temozolomide—melanoma	0.000372	0.0031	CcSEcCtD
Nortriptyline—Thrombocytopenia—Dactinomycin—melanoma	0.000372	0.0031	CcSEcCtD
Nortriptyline—HTR2A—hindlimb—melanoma	0.000372	0.0612	CbGeAlD
Nortriptyline—Anxiety—Carmustine—melanoma	0.00037	0.00308	CcSEcCtD
Nortriptyline—Paraesthesia—Bleomycin—melanoma	0.000366	0.00304	CcSEcCtD
Nortriptyline—Weight increased—Docetaxel—melanoma	0.000366	0.00304	CcSEcCtD
Nortriptyline—Convulsion—Temozolomide—melanoma	0.000365	0.00304	CcSEcCtD
Nortriptyline—Weight decreased—Docetaxel—melanoma	0.000364	0.00303	CcSEcCtD
Nortriptyline—Hypertension—Temozolomide—melanoma	0.000364	0.00303	CcSEcCtD
Nortriptyline—Anorexia—Dactinomycin—melanoma	0.000363	0.00301	CcSEcCtD
Nortriptyline—Confusional state—Carmustine—melanoma	0.000359	0.00298	CcSEcCtD
Nortriptyline—Anxiety—Temozolomide—melanoma	0.000358	0.00297	CcSEcCtD
Nortriptyline—Oedema—Carmustine—melanoma	0.000356	0.00296	CcSEcCtD
Nortriptyline—Discomfort—Temozolomide—melanoma	0.000355	0.00295	CcSEcCtD
Nortriptyline—Decreased appetite—Bleomycin—melanoma	0.000354	0.00295	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Docetaxel—melanoma	0.000354	0.00294	CcSEcCtD
Nortriptyline—Myocardial infarction—Docetaxel—melanoma	0.000352	0.00292	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Docetaxel—melanoma	0.000352	0.00292	CcSEcCtD
Nortriptyline—Dry mouth—Temozolomide—melanoma	0.000351	0.00292	CcSEcCtD
Nortriptyline—Stomatitis—Docetaxel—melanoma	0.00035	0.00291	CcSEcCtD
Nortriptyline—Jaundice—Docetaxel—melanoma	0.00035	0.00291	CcSEcCtD
Nortriptyline—Thrombocytopenia—Carmustine—melanoma	0.000349	0.0029	CcSEcCtD
Nortriptyline—Tachycardia—Carmustine—melanoma	0.000347	0.00289	CcSEcCtD
Nortriptyline—Confusional state—Temozolomide—melanoma	0.000347	0.00288	CcSEcCtD
Nortriptyline—Oedema—Temozolomide—melanoma	0.000344	0.00286	CcSEcCtD
Nortriptyline—Anorexia—Carmustine—melanoma	0.000339	0.00282	CcSEcCtD
Nortriptyline—Thrombocytopenia—Temozolomide—melanoma	0.000337	0.0028	CcSEcCtD
Nortriptyline—Feeling abnormal—Bleomycin—melanoma	0.000336	0.00279	CcSEcCtD
Nortriptyline—Agranulocytosis—Docetaxel—melanoma	0.000335	0.00278	CcSEcCtD
Nortriptyline—Hypotension—Carmustine—melanoma	0.000333	0.00277	CcSEcCtD
Nortriptyline—Hyperhidrosis—Temozolomide—melanoma	0.000333	0.00276	CcSEcCtD
Nortriptyline—Decreased appetite—Dactinomycin—melanoma	0.000331	0.00275	CcSEcCtD
Nortriptyline—Fatigue—Dactinomycin—melanoma	0.000328	0.00273	CcSEcCtD
Nortriptyline—Anorexia—Temozolomide—melanoma	0.000328	0.00273	CcSEcCtD
Nortriptyline—Urticaria—Bleomycin—melanoma	0.000324	0.00269	CcSEcCtD
Nortriptyline—Body temperature increased—Bleomycin—melanoma	0.000322	0.00268	CcSEcCtD
Nortriptyline—Hepatitis—Docetaxel—melanoma	0.000322	0.00268	CcSEcCtD
Nortriptyline—Insomnia—Carmustine—melanoma	0.000322	0.00268	CcSEcCtD
Nortriptyline—Hypoaesthesia—Docetaxel—melanoma	0.00032	0.00266	CcSEcCtD
Nortriptyline—Paraesthesia—Carmustine—melanoma	0.00032	0.00266	CcSEcCtD
Nortriptyline—HTR2A—appendage—melanoma	0.000319	0.0525	CbGeAlD
Nortriptyline—Oedema peripheral—Docetaxel—melanoma	0.000317	0.00264	CcSEcCtD
Nortriptyline—Somnolence—Carmustine—melanoma	0.000316	0.00263	CcSEcCtD
Nortriptyline—Feeling abnormal—Dactinomycin—melanoma	0.000313	0.00261	CcSEcCtD
Nortriptyline—Insomnia—Temozolomide—melanoma	0.000311	0.00259	CcSEcCtD
Nortriptyline—Decreased appetite—Carmustine—melanoma	0.000309	0.00257	CcSEcCtD
Nortriptyline—Paraesthesia—Temozolomide—melanoma	0.000309	0.00257	CcSEcCtD
Nortriptyline—Somnolence—Temozolomide—melanoma	0.000306	0.00254	CcSEcCtD
Nortriptyline—Constipation—Carmustine—melanoma	0.000304	0.00253	CcSEcCtD
Nortriptyline—Dyspepsia—Temozolomide—melanoma	0.000303	0.00252	CcSEcCtD
Nortriptyline—Eye disorder—Docetaxel—melanoma	0.000301	0.0025	CcSEcCtD
Nortriptyline—Abdominal pain—Dactinomycin—melanoma	0.000301	0.0025	CcSEcCtD
Nortriptyline—Body temperature increased—Dactinomycin—melanoma	0.000301	0.0025	CcSEcCtD
Nortriptyline—Hypersensitivity—Bleomycin—melanoma	0.0003	0.0025	CcSEcCtD
Nortriptyline—Decreased appetite—Temozolomide—melanoma	0.000299	0.00249	CcSEcCtD
Nortriptyline—Flushing—Docetaxel—melanoma	0.000299	0.00248	CcSEcCtD
Nortriptyline—Fatigue—Temozolomide—melanoma	0.000297	0.00247	CcSEcCtD
Nortriptyline—Constipation—Temozolomide—melanoma	0.000294	0.00245	CcSEcCtD
Nortriptyline—Feeling abnormal—Carmustine—melanoma	0.000293	0.00244	CcSEcCtD
Nortriptyline—Asthenia—Bleomycin—melanoma	0.000293	0.00243	CcSEcCtD
Nortriptyline—Pruritus—Bleomycin—melanoma	0.000288	0.0024	CcSEcCtD
Nortriptyline—Arrhythmia—Docetaxel—melanoma	0.000288	0.00239	CcSEcCtD
Nortriptyline—Alopecia—Docetaxel—melanoma	0.000285	0.00237	CcSEcCtD
Nortriptyline—CHRM5—eye—melanoma	0.000284	0.0469	CbGeAlD
Nortriptyline—Feeling abnormal—Temozolomide—melanoma	0.000283	0.00236	CcSEcCtD
Nortriptyline—Body temperature increased—Carmustine—melanoma	0.000281	0.00234	CcSEcCtD
Nortriptyline—Abdominal pain—Carmustine—melanoma	0.000281	0.00234	CcSEcCtD
Nortriptyline—Hypersensitivity—Dactinomycin—melanoma	0.00028	0.00233	CcSEcCtD
Nortriptyline—Dysgeusia—Docetaxel—melanoma	0.000274	0.00228	CcSEcCtD
Nortriptyline—Urticaria—Temozolomide—melanoma	0.000273	0.00227	CcSEcCtD
Nortriptyline—Asthenia—Dactinomycin—melanoma	0.000273	0.00227	CcSEcCtD
Nortriptyline—Abdominal pain—Temozolomide—melanoma	0.000272	0.00226	CcSEcCtD
Nortriptyline—Body temperature increased—Temozolomide—melanoma	0.000272	0.00226	CcSEcCtD
Nortriptyline—Hypersensitivity—Carmustine—melanoma	0.000262	0.00218	CcSEcCtD
Nortriptyline—Diarrhoea—Dactinomycin—melanoma	0.00026	0.00216	CcSEcCtD
Nortriptyline—Vomiting—Bleomycin—melanoma	0.000259	0.00216	CcSEcCtD
Nortriptyline—Rash—Bleomycin—melanoma	0.000257	0.00214	CcSEcCtD
Nortriptyline—Dermatitis—Bleomycin—melanoma	0.000257	0.00214	CcSEcCtD
Nortriptyline—Protriptyline—ABCB1—melanoma	0.000256	0.068	CrCbGaD
Nortriptyline—Asthenia—Carmustine—melanoma	0.000255	0.00212	CcSEcCtD
Nortriptyline—Hypersensitivity—Temozolomide—melanoma	0.000253	0.00211	CcSEcCtD
Nortriptyline—Syncope—Docetaxel—melanoma	0.000251	0.00209	CcSEcCtD
Nortriptyline—Leukopenia—Docetaxel—melanoma	0.000251	0.00209	CcSEcCtD
Nortriptyline—Palpitations—Docetaxel—melanoma	0.000248	0.00206	CcSEcCtD
Nortriptyline—CHRM5—skin of body—melanoma	0.000248	0.0408	CbGeAlD
Nortriptyline—Asthenia—Temozolomide—melanoma	0.000247	0.00205	CcSEcCtD
Nortriptyline—Loss of consciousness—Docetaxel—melanoma	0.000246	0.00205	CcSEcCtD
Nortriptyline—Diarrhoea—Carmustine—melanoma	0.000244	0.00203	CcSEcCtD
Nortriptyline—Pruritus—Temozolomide—melanoma	0.000243	0.00202	CcSEcCtD
Nortriptyline—Convulsion—Docetaxel—melanoma	0.000243	0.00202	CcSEcCtD
Nortriptyline—Nausea—Bleomycin—melanoma	0.000242	0.00201	CcSEcCtD
Nortriptyline—Hypertension—Docetaxel—melanoma	0.000242	0.00201	CcSEcCtD
Nortriptyline—Vomiting—Dactinomycin—melanoma	0.000242	0.00201	CcSEcCtD
Nortriptyline—Rash—Dactinomycin—melanoma	0.00024	0.00199	CcSEcCtD
Nortriptyline—Dizziness—Carmustine—melanoma	0.000235	0.00196	CcSEcCtD
Nortriptyline—Diarrhoea—Temozolomide—melanoma	0.000235	0.00196	CcSEcCtD
Nortriptyline—Dry mouth—Docetaxel—melanoma	0.000233	0.00194	CcSEcCtD
Nortriptyline—Confusional state—Docetaxel—melanoma	0.000231	0.00192	CcSEcCtD
Nortriptyline—Oedema—Docetaxel—melanoma	0.000229	0.0019	CcSEcCtD
Nortriptyline—Dizziness—Temozolomide—melanoma	0.000227	0.00189	CcSEcCtD
Nortriptyline—Vomiting—Carmustine—melanoma	0.000226	0.00188	CcSEcCtD
Nortriptyline—Nausea—Dactinomycin—melanoma	0.000226	0.00188	CcSEcCtD
Nortriptyline—Shock—Docetaxel—melanoma	0.000225	0.00187	CcSEcCtD
Nortriptyline—Rash—Carmustine—melanoma	0.000224	0.00187	CcSEcCtD
Nortriptyline—Dermatitis—Carmustine—melanoma	0.000224	0.00186	CcSEcCtD
Nortriptyline—Thrombocytopenia—Docetaxel—melanoma	0.000224	0.00186	CcSEcCtD
Nortriptyline—Tachycardia—Docetaxel—melanoma	0.000223	0.00186	CcSEcCtD
Nortriptyline—Headache—Carmustine—melanoma	0.000223	0.00185	CcSEcCtD
Nortriptyline—Vomiting—Temozolomide—melanoma	0.000219	0.00182	CcSEcCtD
Nortriptyline—Anorexia—Docetaxel—melanoma	0.000218	0.00181	CcSEcCtD
Nortriptyline—Rash—Temozolomide—melanoma	0.000217	0.0018	CcSEcCtD
Nortriptyline—Dermatitis—Temozolomide—melanoma	0.000217	0.0018	CcSEcCtD
Nortriptyline—Headache—Temozolomide—melanoma	0.000215	0.00179	CcSEcCtD
Nortriptyline—Hypotension—Docetaxel—melanoma	0.000214	0.00178	CcSEcCtD
Nortriptyline—PTGS1—endothelium—melanoma	0.000213	0.0351	CbGeAlD
Nortriptyline—Nausea—Carmustine—melanoma	0.000211	0.00176	CcSEcCtD
Nortriptyline—Insomnia—Docetaxel—melanoma	0.000207	0.00172	CcSEcCtD
Nortriptyline—CHRM4—head—melanoma	0.000207	0.034	CbGeAlD
Nortriptyline—Paraesthesia—Docetaxel—melanoma	0.000205	0.00171	CcSEcCtD
Nortriptyline—Nausea—Temozolomide—melanoma	0.000204	0.0017	CcSEcCtD
Nortriptyline—Somnolence—Docetaxel—melanoma	0.000203	0.00169	CcSEcCtD
Nortriptyline—Dyspepsia—Docetaxel—melanoma	0.000201	0.00167	CcSEcCtD
Nortriptyline—Decreased appetite—Docetaxel—melanoma	0.000199	0.00165	CcSEcCtD
Nortriptyline—Fatigue—Docetaxel—melanoma	0.000197	0.00164	CcSEcCtD
Nortriptyline—PTGS1—blood vessel—melanoma	0.000197	0.0324	CbGeAlD
Nortriptyline—Constipation—Docetaxel—melanoma	0.000196	0.00163	CcSEcCtD
Nortriptyline—HTR2A—endothelium—melanoma	0.000192	0.0317	CbGeAlD
Nortriptyline—Epinastine—ABCB1—melanoma	0.00019	0.0504	CrCbGaD
Nortriptyline—Feeling abnormal—Docetaxel—melanoma	0.000188	0.00157	CcSEcCtD
Nortriptyline—HTR6—head—melanoma	0.000185	0.0305	CbGeAlD
Nortriptyline—Oxcarbazepine—ALB—melanoma	0.000183	0.0486	CrCbGaD
Nortriptyline—Body temperature increased—Docetaxel—melanoma	0.000181	0.0015	CcSEcCtD
Nortriptyline—Abdominal pain—Docetaxel—melanoma	0.000181	0.0015	CcSEcCtD
Nortriptyline—HTR2A—blood vessel—melanoma	0.000177	0.0292	CbGeAlD
Nortriptyline—Hypersensitivity—Docetaxel—melanoma	0.000169	0.0014	CcSEcCtD
Nortriptyline—Asthenia—Docetaxel—melanoma	0.000164	0.00136	CcSEcCtD
Nortriptyline—Maprotiline—ABCB1—melanoma	0.000163	0.0434	CrCbGaD
Nortriptyline—Pruritus—Docetaxel—melanoma	0.000162	0.00135	CcSEcCtD
Nortriptyline—CHRM5—head—melanoma	0.000161	0.0266	CbGeAlD
Nortriptyline—Diarrhoea—Docetaxel—melanoma	0.000157	0.0013	CcSEcCtD
Nortriptyline—Dizziness—Docetaxel—melanoma	0.000151	0.00126	CcSEcCtD
Nortriptyline—ADRA1B—head—melanoma	0.000148	0.0243	CbGeAlD
Nortriptyline—Vomiting—Docetaxel—melanoma	0.000145	0.00121	CcSEcCtD
Nortriptyline—ADRA1D—head—melanoma	0.000144	0.0238	CbGeAlD
Nortriptyline—Rash—Docetaxel—melanoma	0.000144	0.0012	CcSEcCtD
Nortriptyline—Dermatitis—Docetaxel—melanoma	0.000144	0.0012	CcSEcCtD
Nortriptyline—Headache—Docetaxel—melanoma	0.000143	0.00119	CcSEcCtD
Nortriptyline—DRD2—eye—melanoma	0.000143	0.0236	CbGeAlD
Nortriptyline—DRD2—retina—melanoma	0.000142	0.0234	CbGeAlD
Nortriptyline—Nausea—Docetaxel—melanoma	0.000136	0.00113	CcSEcCtD
Nortriptyline—HTR2A—neck—melanoma	0.000127	0.0209	CbGeAlD
Nortriptyline—HRH1—eye—melanoma	0.000113	0.0186	CbGeAlD
Nortriptyline—CHRM2—head—melanoma	0.000111	0.0183	CbGeAlD
Nortriptyline—HTR2C—head—melanoma	0.000107	0.0176	CbGeAlD
Nortriptyline—Clomipramine—ALB—melanoma	0.000105	0.0279	CrCbGaD
Nortriptyline—SLC6A4—head—melanoma	0.000101	0.0167	CbGeAlD
Nortriptyline—CHRM1—head—melanoma	0.000101	0.0166	CbGeAlD
Nortriptyline—Clomipramine—ABCB1—melanoma	0.0001	0.0267	CrCbGaD
Nortriptyline—Chlorprothixene—ABCB1—melanoma	9.99e-05	0.0265	CrCbGaD
Nortriptyline—HTR2A—eye—melanoma	9.44e-05	0.0156	CbGeAlD
Nortriptyline—HTR2A—retina—melanoma	9.36e-05	0.0154	CbGeAlD
Nortriptyline—Trimipramine—ABCB1—melanoma	9.24e-05	0.0245	CrCbGaD
Nortriptyline—PTGS1—skin of body—melanoma	9.1e-05	0.015	CbGeAlD
Nortriptyline—CHRM3—head—melanoma	9.03e-05	0.0149	CbGeAlD
Nortriptyline—HTR1A—head—melanoma	8.99e-05	0.0148	CbGeAlD
Nortriptyline—HRH1—mammalian vulva—melanoma	8.97e-05	0.0148	CbGeAlD
Nortriptyline—SLC6A2—head—melanoma	8.92e-05	0.0147	CbGeAlD
Nortriptyline—Doxepin—ABCB1—melanoma	8.8e-05	0.0234	CrCbGaD
Nortriptyline—ORM1—lymph node—melanoma	8.32e-05	0.0137	CbGeAlD
Nortriptyline—PTGS1—mammalian vulva—melanoma	8.3e-05	0.0137	CbGeAlD
Nortriptyline—ADRA1A—head—melanoma	8.29e-05	0.0137	CbGeAlD
Nortriptyline—DRD2—head—melanoma	8.13e-05	0.0134	CbGeAlD
Nortriptyline—Desipramine—ABCB1—melanoma	8.08e-05	0.0214	CrCbGaD
Nortriptyline—ALB—lymph node—melanoma	7.3e-05	0.012	CbGeAlD
Nortriptyline—Amitriptyline—ALB—melanoma	7.13e-05	0.0189	CrCbGaD
Nortriptyline—Imipramine—ABCB1—melanoma	6.85e-05	0.0182	CrCbGaD
Nortriptyline—Amitriptyline—ABCB1—melanoma	6.81e-05	0.0181	CrCbGaD
Nortriptyline—HRH1—head—melanoma	6.42e-05	0.0106	CbGeAlD
Nortriptyline—SLC6A2—lymph node—melanoma	6.24e-05	0.0103	CbGeAlD
Nortriptyline—CYP2E1—head—melanoma	6.17e-05	0.0102	CbGeAlD
Nortriptyline—PTGS1—head—melanoma	5.94e-05	0.00979	CbGeAlD
Nortriptyline—HTR2A—head—melanoma	5.36e-05	0.00883	CbGeAlD
Nortriptyline—CYP2D6—head—melanoma	4.88e-05	0.00804	CbGeAlD
Nortriptyline—HRH1—lymph node—melanoma	4.49e-05	0.0074	CbGeAlD
Nortriptyline—PTGS1—lymph node—melanoma	4.16e-05	0.00685	CbGeAlD
Nortriptyline—CYP2D6—Metabolism—PPARG—melanoma	3.39e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NRAS—melanoma	3.39e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCND1—melanoma	3.38e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—STAT3—melanoma	3.38e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NRAS—melanoma	3.37e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCND1—melanoma	3.37e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CTNNB1—melanoma	3.36e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARG—melanoma	3.36e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CTNNB1—melanoma	3.36e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CD—melanoma	3.36e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—melanoma	3.35e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HRAS—melanoma	3.35e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CTNNB1—melanoma	3.35e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—KRAS—melanoma	3.34e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CDKN1A—melanoma	3.34e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCND1—melanoma	3.34e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CTNNB1—melanoma	3.34e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PTEN—melanoma	3.33e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCND1—melanoma	3.33e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NFKB1—melanoma	3.32e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—melanoma	3.31e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CTNNB1—melanoma	3.3e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—melanoma	3.3e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—melanoma	3.3e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CTNNB1—melanoma	3.29e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—melanoma	3.29e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CDKN1A—melanoma	3.29e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—melanoma	3.28e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CDKN1A—melanoma	3.28e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PTEN—melanoma	3.28e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTEN—melanoma	3.28e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PTEN—melanoma	3.27e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—melanoma	3.27e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTEN—melanoma	3.27e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CDKN1A—melanoma	3.27e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PIK3CA—melanoma	3.27e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—melanoma	3.27e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NFKB1—melanoma	3.26e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PTEN—melanoma	3.26e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CDKN1A—melanoma	3.26e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CB—melanoma	3.26e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NFKB1—melanoma	3.26e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—melanoma	3.25e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PTEN—melanoma	3.25e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NFKB1—melanoma	3.25e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK3—melanoma	3.24e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—melanoma	3.24e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NFKB1—melanoma	3.24e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—melanoma	3.23e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—melanoma	3.23e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—melanoma	3.23e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CDKN1A—melanoma	3.23e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK3—melanoma	3.23e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NRAS—melanoma	3.23e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PTEN—melanoma	3.22e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CDKN1A—melanoma	3.22e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PTEN—melanoma	3.21e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NFKB1—melanoma	3.2e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—melanoma	3.2e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—melanoma	3.2e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NFKB1—melanoma	3.2e-06	2e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—melanoma	3.19e-06	2e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCB1—melanoma	3.18e-06	2e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—melanoma	3.18e-06	2e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—melanoma	3.17e-06	1.99e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—melanoma	3.16e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HRAS—melanoma	3.16e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MYC—melanoma	3.15e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—melanoma	3.14e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MYC—melanoma	3.14e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—melanoma	3.13e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.12e-06	1.96e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PIK3CA—melanoma	3.09e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK3—melanoma	3.09e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CD—melanoma	3.09e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK1—melanoma	3.09e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EGFR—melanoma	3.09e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PIK3CA—melanoma	3.07e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK1—melanoma	3.07e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EGFR—melanoma	3.07e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CD—melanoma	3.06e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—melanoma	3.05e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HRAS—melanoma	3.02e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—melanoma	3.02e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—melanoma	3.02e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—melanoma	3.01e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MYC—melanoma	3e-06	1.88e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—melanoma	2.98e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CG—melanoma	2.97e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NRAS—melanoma	2.97e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—melanoma	2.97e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—melanoma	2.96e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—melanoma	2.96e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—melanoma	2.96e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—melanoma	2.95e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK1—melanoma	2.94e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EGFR—melanoma	2.94e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—melanoma	2.94e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—melanoma	2.93e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PRKCA—melanoma	2.93e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—melanoma	2.93e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NRAS—melanoma	2.93e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CB—melanoma	2.93e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NRAS—melanoma	2.92e-06	1.83e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—melanoma	2.92e-06	1.83e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—KRAS—melanoma	2.91e-06	1.83e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NRAS—melanoma	2.91e-06	1.83e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—melanoma	2.91e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—melanoma	2.91e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ERCC2—melanoma	2.91e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NRAS—melanoma	2.9e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—melanoma	2.9e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—KRAS—melanoma	2.9e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—melanoma	2.9e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—melanoma	2.89e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—melanoma	2.88e-06	1.81e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NRAS—melanoma	2.87e-06	1.8e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—melanoma	2.87e-06	1.8e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARG—melanoma	2.87e-06	1.8e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NRAS—melanoma	2.86e-06	1.8e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK3—melanoma	2.85e-06	1.79e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HRAS—melanoma	2.84e-06	1.78e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTEN—melanoma	2.82e-06	1.77e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK3—melanoma	2.8e-06	1.76e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK3—melanoma	2.8e-06	1.75e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—melanoma	2.79e-06	1.75e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK3—melanoma	2.79e-06	1.75e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK3—melanoma	2.78e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—KRAS—melanoma	2.78e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MYC—melanoma	2.77e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK3—melanoma	2.75e-06	1.73e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK3—melanoma	2.74e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PIK3CA—melanoma	2.74e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MYC—melanoma	2.73e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—melanoma	2.72e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MYC—melanoma	2.72e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MYC—melanoma	2.71e-06	1.7e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK1—melanoma	2.71e-06	1.7e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGFR—melanoma	2.71e-06	1.7e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MYC—melanoma	2.7e-06	1.69e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CB—melanoma	2.69e-06	1.69e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PIK3CA—melanoma	2.68e-06	1.68e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MYC—melanoma	2.68e-06	1.68e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—melanoma	2.67e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MYC—melanoma	2.67e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CB—melanoma	2.67e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK1—melanoma	2.67e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—melanoma	2.67e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGFR—melanoma	2.67e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PIK3CA—melanoma	2.66e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK1—melanoma	2.66e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGFR—melanoma	2.66e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK1—melanoma	2.65e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGFR—melanoma	2.65e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK1—melanoma	2.64e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—melanoma	2.64e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGFR—melanoma	2.64e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK1—melanoma	2.62e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGFR—melanoma	2.62e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CD—melanoma	2.62e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK1—melanoma	2.61e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGFR—melanoma	2.61e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—melanoma	2.59e-06	1.63e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—melanoma	2.58e-06	1.62e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—melanoma	2.58e-06	1.62e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—KRAS—melanoma	2.56e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PIK3CA—melanoma	2.55e-06	1.6e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTEN—melanoma	2.53e-06	1.59e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—melanoma	2.53e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—KRAS—melanoma	2.52e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—KRAS—melanoma	2.51e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—melanoma	2.51e-06	1.57e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—KRAS—melanoma	2.5e-06	1.57e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—KRAS—melanoma	2.5e-06	1.57e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HRAS—melanoma	2.48e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—KRAS—melanoma	2.47e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—melanoma	2.47e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—KRAS—melanoma	2.47e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HRAS—melanoma	2.46e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—melanoma	2.37e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HRAS—melanoma	2.36e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—melanoma	2.36e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PIK3CA—melanoma	2.35e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTEN—melanoma	2.33e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.31e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PIK3CA—melanoma	2.31e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PIK3CA—melanoma	2.31e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PIK3CA—melanoma	2.31e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTEN—melanoma	2.3e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PIK3CA—melanoma	2.3e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CG—melanoma	2.3e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PIK3CA—melanoma	2.29e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CB—melanoma	2.28e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—melanoma	2.27e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.27e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PIK3CA—melanoma	2.27e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—melanoma	2.26e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—melanoma	2.26e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—melanoma	2.24e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—melanoma	2.24e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—melanoma	2.23e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—melanoma	2.23e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—melanoma	2.22e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARG—melanoma	2.22e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—melanoma	2.2e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—melanoma	2.19e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—melanoma	2.19e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—melanoma	2.18e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HRAS—melanoma	2.18e-06	1.36e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HRAS—melanoma	2.14e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HRAS—melanoma	2.14e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HRAS—melanoma	2.13e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HRAS—melanoma	2.12e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HRAS—melanoma	2.1e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HRAS—melanoma	2.1e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—melanoma	2.08e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—melanoma	2.08e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—melanoma	2.05e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—melanoma	2.04e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—melanoma	2.04e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—melanoma	2.03e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CD—melanoma	2.02e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—melanoma	2.01e-06	1.26e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—melanoma	2.01e-06	1.26e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—melanoma	1.99e-06	1.25e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CA—melanoma	1.99e-06	1.25e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTEN—melanoma	1.97e-06	1.24e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—melanoma	1.92e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—melanoma	1.89e-06	1.19e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—melanoma	1.89e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—melanoma	1.89e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—melanoma	1.88e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—melanoma	1.88e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—melanoma	1.87e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—melanoma	1.86e-06	1.16e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—melanoma	1.85e-06	1.16e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CA—melanoma	1.78e-06	1.12e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CB—melanoma	1.76e-06	1.1e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—melanoma	1.74e-06	1.09e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CA—melanoma	1.64e-06	1.03e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CA—melanoma	1.63e-06	1.02e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—melanoma	1.62e-06	1.02e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTEN—melanoma	1.52e-06	9.54e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—melanoma	1.46e-06	9.14e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CA—melanoma	1.39e-06	8.72e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—melanoma	1.34e-06	8.41e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—melanoma	1.33e-06	8.33e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—melanoma	1.14e-06	7.12e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CA—melanoma	1.07e-06	6.73e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—melanoma	8.76e-07	5.5e-06	CbGpPWpGaD
